Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids
- Conditions
- Interventions
- First Posted Date
- 2009-04-16
- Last Posted Date
- 2014-07-08
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 144
- Registration Number
- NCT00882258
- Locations
- 🇺🇸
Visions Clinical Research Tuscon, Tuscon, Arizona, United States
🇺🇸Visions Clinical Research, Boynton Beach, Florida, United States
🇺🇸Downtown Women's Health Care, Denver, Colorado, United States
Study to Evaluate Menses Induction in Women Administered Proellex
- First Posted Date
- 2009-04-15
- Last Posted Date
- 2014-08-25
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 11
- Registration Number
- NCT00881608
- Locations
- 🇺🇸
Advances in Health Inc., Houston, Texas, United States
Investigate Absorption, Metabolism and Excretion of [14C}-Proellex Following Single Oral Dose in Healthy Females
- First Posted Date
- 2009-04-15
- Last Posted Date
- 2014-07-08
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT00881062
- Locations
- 🇺🇸
Covance Clinical Research Unit Inc., Madison, Wisconsin, United States
Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms
- First Posted Date
- 2009-04-02
- Last Posted Date
- 2014-06-27
- Lead Sponsor
- Repros Therapeutics Inc.
- Registration Number
- NCT00874302
- Locations
- 🇺🇸
Genesis Center for Clinical Research, San Diego, California, United States
🇺🇸Thomas Jefferson University - Jefferson Center for Women's Medical Specialties, Philadelphia, Pennsylvania, United States
🇧🇷Universidade Federal de São Paulo - UNIFESP, São Paulo, Brazil
Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids
- First Posted Date
- 2009-03-02
- Last Posted Date
- 2014-08-21
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 71
- Registration Number
- NCT00853567
- Locations
- 🇺🇸
Comprehensive Clinical Trials, LLC, West Palm Beach, Florida, United States
🇺🇸Central Brooklyn Medical Group (eCast), Brooklyn, New York, United States
🇺🇸Impact Clinical Trials, Los Angeles, California, United States
Evaluate PK and Safety of Proellex® in Females With Various Stages of Impaired Renal Function and Healthy Females
- First Posted Date
- 2008-11-07
- Last Posted Date
- 2014-08-25
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT00787618
- Locations
- 🇺🇸
New Orleans Center for Clinical Research - Knoxville, Knoxville, Tennessee, United States
🇺🇸DaVita Clinical Research, Minneapolis, Minnesota, United States
🇺🇸Clinical Pharmacology of Miami, Inc, Miami, Florida, United States
Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids
- Conditions
- Interventions
- First Posted Date
- 2008-11-05
- Last Posted Date
- 2014-08-21
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT00785356
- Locations
- 🇲🇽
Comité para la Prevención de la Osteoporosis COMOP, Mexico City, Federal District, Mexico
🇲🇽Hospital Universitario "Dr. José Eleuterio González" Facultad de Medicina de la Universidad Autónoma de Nuevo León (UANL), Monterrey, Nuevo León, Mexico
🇲🇽Instituto Nacional de Perinatología "Isidro Espinosa de los Reyes", Mexico City, Federal District, Mexico
Crossover Study of the Safety and PK Properties of Proellex®
- First Posted Date
- 2008-09-09
- Last Posted Date
- 2019-04-29
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT00749879
- Locations
- 🇺🇸
Healthcare Discoveries Inc., San Antonio, Texas, United States
Evaluate the Safety and PK of Proellex® in Female Patients With Impaired Hepatic Function and Healthy Adults
- First Posted Date
- 2008-08-26
- Last Posted Date
- 2014-08-28
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT00741273
- Locations
- 🇺🇸
Clinical Pharmacology of Miami, Inc., Miami, Florida, United States
🇺🇸Orlando Clinical Research Center, Orlando, Florida, United States
Open-Label, Multiple-Dose, Non-Randomized Study to Assess Drug-Drug Interactions of Proellex® in Female Subjects
- Conditions
- Interventions
- First Posted Date
- 2008-08-26
- Last Posted Date
- 2014-08-22
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT00741468
- Locations
- 🇺🇸
Clinical Research Center Advanced Biomedical Research Inc., Hackensack, New Jersey, United States